Article

Clarity Medical Systems obtains patent

Clarity Medical Systems Inc. has received a patent on optimizing vision correction procedures from the U.S. Patent and Trademark Office.

 

Pleasanton, CA-Clarity Medical Systems Inc. has received a patent on optimizing vision correction procedures from the U.S. Patent and Trademark Office.

The patent, which is a continuation of Clarity’s expanding HOLOS technology portfolio, includes the capture and display of high accuracy continuous intraoperative wavefront aberrometry.

“We believe this unique capability will provide the opportunity to deploy HOLOS to help ophthalmologists more rapidly and efficiently measure the patient’s refractive state during vision correction procedures, including assisting surgeons as a refractive guidance tool intraoperatively,” said Keith Mullowney, president and chief executive officer of Clarity.

Clarity’s first product application of the technology will be for refractive cataract surgery with HOLOS IntraOp-an intraoperative module that attaches to standard surgical microscopes to assist the surgeon in monitoring and confirming the refractive status of the patient’s eye throughout all phases of the surgical procedure.

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.